https://markets.businessinsider.com/news/stocks/gh-research-announces-publication-of-phase-2b-results-for-mebufotenin-gh001-in-jama-psychiatry-and-reports-new-finding-of-severity-independent-efficacy-in-trd-1035962968
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry...
Phase 2b results for GH001 in TRD now published and peer-reviewed in JAMA Psychiatry New peer-reviewed article in forthcoming issue of Psychopharm...